Quality & Patient Safety
The Joint Commission and National Quality Forum yesterday presented 2018 John M. Eisenberg Patient Safety and Quality Awards to a health system, network of children鈥檚 hospitals, and physician at the NQF annual conference in Washington, D.C.
The Food and Drug Administration Friday issued warning letters to all three duodenoscope manufacturers for failing to comply with a 2015 order to conduct postmarket surveillance studies to determine whether health care facilities are able to properly clean and disinfect the devices.
Nancy Agee highlighted the importance of a 鈥渃ulture of caring鈥 and curiosity to 鈥渁 high-quality, highly reliable organization.鈥
Please take the opportunity this week to share your work and resources on patient safety, safety culture and patient engagement with your community.
AHA responds to the Centers for Medicare Medicaid Services' request for information on revisions to personnel regulations, proficiency testing (PT) referral, histocompatibility regulations, and fee regulations under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
Sutter Health, located in northern California, uses an artificial intelligence platform to reduce inpatient drug spending, decrease lengths of stay and improve quality and safety. Click the resource below to learn more
AONE member Sue Hassmiller, senior adviser for nursing at the Robert Wood Johnson Foundation, spoke at the official U.S. launch of a global campaign spearheaded by the International Council of Nurses and the World Health Organization.
Hospira is voluntarily recalling three lots of the injectable opioid medication Hydromorphone HCl because the glass vials may be broken or cracked.
Member Advisory: Patient Safety Awareness Week March 11-17: Opportunity to Share Your Hospital Story
Patient Safety Awareness Week (PSAW) will be March 11-17. Once again, this celebration is sponsored by the National Patient Safety Foundation (NPSF), which began working together with the Institute for Healthcare Improvement (IHI) last year.
The Food and Drug Administration yesterday alerted health care professionals and patients not to use drug products produced by Cantrell Drug Co., including opioid products and other drugs intended for sterile injection, citing serious deficiencies in the company鈥檚 compounding operations.